000 01334 a2200361 4500
005 20250515093104.0
264 0 _c20080215
008 200802s 0 0 spa d
022 _a0365-6691
024 7 _a10.4321/s0365-66912007001100004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBendala-Tufanisco, E
245 0 0 _a[Antioxidants treatment of ocular diseases].
_h[electronic resource]
260 _bArchivos de la Sociedad Espanola de Oftalmologia
_cNov 2007
300 _a673; author reply 673-4 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntioxidants
_xadverse effects
650 0 4 _aAscorbic Acid
_xadverse effects
650 0 4 _aCataract
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aDietary Supplements
650 0 4 _aEye Diseases
_xdrug therapy
650 0 4 _aGlaucoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMacular Degeneration
_xdrug therapy
650 0 4 _aRisk Factors
650 0 4 _aSmoking
_xadverse effects
650 0 4 _aVitamin E
_xadverse effects
650 0 4 _aVitamins
_xadverse effects
700 1 _aGrisolĂ­a, S
773 0 _tArchivos de la Sociedad Espanola de Oftalmologia
_gvol. 82
_gno. 11
_gp. 673; author reply 673-4
856 4 0 _uhttps://doi.org/10.4321/s0365-66912007001100004
_zAvailable from publisher's website
999 _c17497243
_d17497243